Advertisement

Topics

Novo manufacturing subsidiary completes Budapest expansion

09:12 EDT 24 Aug 2017 | BioPharmaDive

Xellia Pharmaceuticals has a new 32,000-square-foot facility to boost its anti-infective production capabilities.

Original Article: Novo manufacturing subsidiary completes Budapest expansion

NEXT ARTICLE

More From BioPortfolio on "Novo manufacturing subsidiary completes Budapest expansion"

Advertisement
Quick Search
Advertisement
Advertisement